Pilar Sánchez-Corral Selected Research

factor H-related protein 1

1/2022	Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy.
8/2012	Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.
8/2011	Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pilar Sánchez-Corral Research Topics

Disease

21	Atypical Hemolytic Uremic Syndrome 01/2021 - 12/2002
7	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 02/2021 - 05/2008
5	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 05/2008
5	Thrombotic Microangiopathies 10/2015 - 09/2010
3	Infections 02/2021 - 05/2008
3	Hypertension (High Blood Pressure) 01/2021 - 02/2012
3	Renal Insufficiency (Renal Failure) 09/2014 - 03/2007
3	Hemolysis 01/2014 - 08/2011
2	Inflammation (Inflammations) 06/2013 - 08/2012
2	Hemolytic-Uremic Syndrome 08/2011 - 12/2002
1	Chronic Renal Insufficiency 01/2022
1	Disease Susceptibility (Diathesis) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Hematologic Diseases (Blood Diseases) 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Kidney Diseases (Kidney Disease) 01/2019
1	Hereditary Complement Deficiency Diseases 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Acquired Partial Lipodystrophy 01/2019
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2014
1	Opportunistic Infections (Opportunistic Infection) 01/2014
1	Pulmonary Edema 01/2014
1	Heart Failure 01/2014
1	Paraproteinemias (Monoclonal Gammopathy) 04/2012
1	Autoimmune Diseases (Autoimmune Disease) 05/2008
1	Complement Factor H Deficiency 05/2008
1	Meningitis 05/2008
1	Hemolytic Anemia 03/2007
1	Thrombocytopenia (Thrombopenia) 03/2007

Drug/Important Bio-Agent (IBA)

19	Complement System Proteins (Complement)IBA 01/2022 - 12/2002
17	Complement Factor H (Factor H)IBA 02/2021 - 12/2002
9	AutoantibodiesIBA 01/2019 - 11/2009
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2008
4	Fibrinogen (Factor I)FDA Link 07/2008 - 04/2006
3	factor H-related protein 1IBA 01/2022 - 08/2011
3	Complement Factor B (Factor B)IBA 01/2021 - 01/2007
3	Membrane Cofactor ProteinIBA 07/2008 - 04/2006
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	EpitopesIBA 02/2016
1	Complement C3 (C3 Complement)IBA 08/2015
1	ThrombomodulinIBA 09/2014
1	Diacylglycerol KinaseIBA 09/2014
1	CreatinineIBA 01/2014
1	PTX3 proteinIBA 08/2012
1	Dichlorodiphenyldichloroethane (DDD)IBA 04/2012
1	Complement Inactivating AgentsIBA 02/2012
1	eculizumab FDA Link 02/2012
1	Immunoglobulin G (IgG)IBA 08/2011
1	A-factor (Streptomyces)IBA 08/2011
1	DNA (Deoxyribonucleic Acid)IBA 07/2008
1	Amino Acids FDA Link 12/2002

Therapy/Procedure

2	Nephrectomy 01/2021 - 01/2014
1	Kidney Transplantation 01/2021
1	Renal Dialysis (Hemodialysis) 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Peritoneal Dialysis 01/2021
1	Therapeutics 09/2014
1	Transplantation 09/2010